<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8909</journal-id>
<journal-title><![CDATA[Medicina crítica (Colegio Mexicano de Medicina Crítica)]]></journal-title>
<abbrev-journal-title><![CDATA[Med. crít. (Col. Mex. Med. Crít.)]]></abbrev-journal-title>
<issn>2448-8909</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Medicina Crítica A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-89092018000200006</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Norepinefrina/vasopresina versus norepinefrina en pacientes politraumatizados con traumatismo craneoencefálico severo]]></article-title>
<article-title xml:lang="en"><![CDATA[Norepinephrine/vasopressin versus norepinephrine, in polytraumatized patients with severe traumatic brain injury]]></article-title>
<article-title xml:lang="pt"><![CDATA[Norepinefrina/vasopressina vs norepinefrina em pacientes com traumatismo cranioencefálico grave]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ortega Pérez]]></surname>
<given-names><![CDATA[Abad Quetzalcoatl]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Silva Medina]]></surname>
<given-names><![CDATA[Marco Antonio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gaona Valle]]></surname>
<given-names><![CDATA[Laura Soraya]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto de Salud del Estado de México Centro Médico «Lic. Adolfo López Mateos» ]]></institution>
<addr-line><![CDATA[ Estado de México]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2018</year>
</pub-date>
<volume>32</volume>
<numero>2</numero>
<fpage>93</fpage>
<lpage>99</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-89092018000200006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-89092018000200006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-89092018000200006&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  Los pacientes politraumatizados desarrollan una respuesta inflamatoria sistémica y sucesos quimiotácticos similares a los observados en procesos infecciosos; de éstos los que además presentan TCE severo requieren mantenimiento de presión arterial media (TAM) &#8805; 90 mmHg, lo que conlleva la necesidad de dosis altas de vasopresores.  Objetivo:  Evaluar los efectos hemodinámicos de la administración de norepinefrina/vasopresina (grupo experimental) versus norepinefrina (grupo control) en pacientes politraumatizados con traumatismo craneoencefálico severo hemodinámicamente inestables.  Material y métodos:  Ensayo clínico controlado, no aleatorizado, abierto y de grupos paralelos.  Resultados:  Se obtuvo una muestra homogénea de 20 pacientes; ambos grupos mantuvieron las medianas de TAM similares [experimental 90 versus control 93 mmHg, p = 0.516]. Los efectos hemodinámicos a favor del grupo experimental fueron: presión arterial sistólica (PAS) [primera hora, p = .041], frecuencia cardiaca (FC) [primera hora p = .029] así como lactato [hora 5, p = .015]. En cuanto al balance hídrico, la mediana del grupo control fue de +1,516 mL versus +553 mL del grupo experimental [p = 0.579].  Conclusión:  No existe diferencia significativa en la TAM en la reanimación y neuroprotección de ambos grupos. Hubo mejoría estadísticamente significativa en la TAS y FC en la primera hora a favor del grupo experimental.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  The politraumatized patients develop a systemic inflammatory response and quimiotaxis cascade like the infectious diseases; from this kind of patients, those with severe traumatic brain injury, need to hold medium arterial pressure &#8805; 90 mmHg, that triggers high doses of vasopressor.  Objective:  Evaluate hemodynamic repercussion, of infusion Vasopressin/Norepinephrine (experimental group) vs Norepinephrine (control group) in politraumatized patients with severe traumatic brain injury whom present hemodynamic instability.  Material and methods:  Controlled, non randomized and open trial, with parallel groups.  Results:  We got a standardized sample of 20 patients; both groups had the same median of mean arterial pressure (MAP) [experimental group 90 versus control group 93 mmHg, p = 0.516]. There were better hemodynamic effect in experimental group, in systolic arterial pressure (SAP) [first hour, p = .041], heart rate (HR) [first hour p = .029], and lactate [hour 5, p = .015]. The fluid balance&#8217;s median in control group was +1,516 mL versus +553 mL in experimental group [p = 0.579].  Conclusion:  There was no significant difference in MAP of both groups, in reanimation period either neurological protection therapy. There was statistically significant improvement in SAP and HR, in experimental group.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução:  Os pacientes politraumatizados desenvolvem uma resposta inflamatória sistêmica e eventos quimiotáticos semelhantes aos observados em processos infecciosos; destes, os que además apresentam TCE grave requerem manter a pressão arterial média (PAM) &#8805; 90 mmHg, o que leva à necessidade de altas doses de vasopressores.  Objetivo:  Avaliar os efeitos hemodinâmicos da administração de norepinefrina/vasopressina (grupo experimental) contra norepinefrina (grupo controle), em pacientes politraumatizado com traumatismo cranioencefálico grave, que apresentam instabilidade hemodinâmica.  Material e métodos:  Ensaio clínico controlado, não randomizado, aberto e com grupos paralelos.  Resultados:  Obteve-se uma amostra homogênea de 20 pacientes; ambos os grupos mantiveram médias PAM similares [experimental 90 versus controle 93 mmHg, p = 0.516]; Os efeitos hemodinâmicos a favor do grupo experimental foram: pressão arterial sistólica (PAS) [1o hora, p = .041], freqüência cardíaca (FC) [1o hora p = 0.029], bem como lactato [5o, p = 0.015]; Em relação ao balanço hídrico, a mediana do grupo controle foi +1,516 ml vs + 553 ml do grupo experimental [p = 0.579].  Conclusão:  Não há diferença significativa na PAM, na ressuscitação e neuroproteção de ambos os grupos. Houve melhora estatisticamente significativa na PAS e FC na primeira hora a favor do grupo experimental.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Vasopresina]]></kwd>
<kwd lng="es"><![CDATA[norepinefrina]]></kwd>
<kwd lng="es"><![CDATA[politraumatizado]]></kwd>
<kwd lng="es"><![CDATA[traumatismo craneoencefálico severo]]></kwd>
<kwd lng="es"><![CDATA[inestabilidad hemodinámica]]></kwd>
<kwd lng="en"><![CDATA[Vasopressin]]></kwd>
<kwd lng="en"><![CDATA[norepinephrine]]></kwd>
<kwd lng="en"><![CDATA[politraumatized]]></kwd>
<kwd lng="en"><![CDATA[severe traumatic brain injury]]></kwd>
<kwd lng="en"><![CDATA[hemodynamic instability]]></kwd>
<kwd lng="pt"><![CDATA[Vasopressina]]></kwd>
<kwd lng="pt"><![CDATA[norepinefrina]]></kwd>
<kwd lng="pt"><![CDATA[politraumatizado]]></kwd>
<kwd lng="pt"><![CDATA[traumatismo cranioencefálico grave]]></kwd>
<kwd lng="pt"><![CDATA[instabilidade hemodinâmica]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Errington]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Rocha]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The secretion and clearance of vasopressin during the development of irreversible haemorrhagic shock]]></article-title>
<source><![CDATA[J Physiol (Lond)]]></source>
<year>1971</year>
<volume>217</volume>
<page-range>43-5</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Landry]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[Levin]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Gallant]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Ashton]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Seo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[D&#8217;Alessandro]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vasopressin deficiency contributes to the vasodilation of septic shock]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>1997</year>
<volume>95</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1122-5</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wenzel]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Lindner]]></surname>
<given-names><![CDATA[KH]]></given-names>
</name>
<name>
<surname><![CDATA[Prengel]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Maier]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Voelckel]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Lurie]]></surname>
<given-names><![CDATA[KG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vasopressin improves vital organ blood flow after prolonged cardiac arrest with postcounter shock pulseless electrical activity in pigs]]></article-title>
<source><![CDATA[Critical Care Medicine]]></source>
<year>1999</year>
<volume>27</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>486-92</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Robertson]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The regulation of vasopressin functions in health and disease]]></article-title>
<source><![CDATA[Recent Prog Horm Res]]></source>
<year>1976</year>
<volume>33</volume>
<page-range>333-85</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leng]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Russell]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Physiological pathways regulating the activity of magnocellular neurosecretory cells]]></article-title>
<source><![CDATA[Prog Neurobiol]]></source>
<year>1999</year>
<volume>57</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>625-55</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sklar]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Schrier]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Central nervous system mediators of vasopressin release]]></article-title>
<source><![CDATA[Physiol Rev]]></source>
<year>1983</year>
<volume>63</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1243-80</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bourque]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Oliet]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Richard]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Osmoreceptors, osmoreception and osmoregulation]]></article-title>
<source><![CDATA[Front Neuroendocrinol]]></source>
<year>1994</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>231-74</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schrier]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Berl]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Osmotic and nonosmotic control of vasopressin release]]></article-title>
<source><![CDATA[Am J Physiol]]></source>
<year>1979</year>
<volume>236</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>F321-32</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Robertson]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Shelton]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Athar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The osmoregulation of vasopressin]]></article-title>
<source><![CDATA[Kidney Int]]></source>
<year>1976</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>25-37</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thrasher]]></surname>
<given-names><![CDATA[TN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Baroreceptor regulation of vasopressin and renin secretion: low-pressure versus high-pressure receptors]]></article-title>
<source><![CDATA[Front Neuroendocrinol]]></source>
<year>1994</year>
<volume>15</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>157-96</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reid]]></surname>
<given-names><![CDATA[IA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Role of nitric oxide in the regulation of renin and vasopressin secretion]]></article-title>
<source><![CDATA[Front Neuroendocrinol]]></source>
<year>1994</year>
<volume>15</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>351-83</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bichet]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vasopressin receptors in health and disease]]></article-title>
<source><![CDATA[Kidney Int]]></source>
<year>1996</year>
<volume>49</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1706-11</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Riphagen]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Pttman]]></surname>
<given-names><![CDATA[QJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Arginine vasopressin as a central neurotransmitter]]></article-title>
<source><![CDATA[Fed Proc]]></source>
<year>1986</year>
<volume>45</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>2318-22</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramírez]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[VI]]></given-names>
</name>
<name>
<surname><![CDATA[Domínguez]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Barba]]></surname>
<given-names><![CDATA[FC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Respuesta metabólica al trauma]]></article-title>
<source><![CDATA[Medicrit]]></source>
<year>2008</year>
<volume>5</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>130-3</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[ND]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Alfonso]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Quintana]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic response in trauma]]></article-title>
<source><![CDATA[Revista Cubana de Medicina Militar]]></source>
<year>2012</year>
<volume>41</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>96-104</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cuacuas]]></surname>
<given-names><![CDATA[CV]]></given-names>
</name>
<name>
<surname><![CDATA[Escobar]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trauma de alta energía y su respuesta inflamatoria sistémica]]></article-title>
<source><![CDATA[Ortho-tips]]></source>
<year>2008</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>39-50</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alted]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bermejo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chico]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actualizaciones en el manejo del traumatismo craneoencefálico grave]]></article-title>
<source><![CDATA[Med Intensiva]]></source>
<year>2009</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>16-30</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrillo]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Leal]]></surname>
<given-names><![CDATA[GP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Actualidades de fármacos vasopresores e inotrópicos en anestesia]]></article-title>
<source><![CDATA[Rev Mex Anest]]></source>
<year>2009</year>
<volume>32</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>S74-6</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chandler]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Waterhouse]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Wen-Jun]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[New perspectives on catecholaminergic regulation of executive circuits]]></article-title>
<source><![CDATA[Front Neural Circuits]]></source>
<year>2014</year>
<volume>21</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>53-63</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haddad]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
<name>
<surname><![CDATA[Arabi]]></surname>
<given-names><![CDATA[YM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Critical care management of severe traumatic brain injury in adults]]></article-title>
<source><![CDATA[Scand J Trauma Resusc Emerg Med]]></source>
<year>2012</year>
<volume>20</volume>
<page-range>12</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Voelckel]]></surname>
<given-names><![CDATA[WG]]></given-names>
</name>
<name>
<surname><![CDATA[Raedler]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Wenzel]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Lindner]]></surname>
<given-names><![CDATA[KH]]></given-names>
</name>
<name>
<surname><![CDATA[Krismer]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Schmittinger]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs]]></article-title>
<source><![CDATA[Crit Care Med]]></source>
<year>2003</year>
<volume>31</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1160-5</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sanui]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[King]]></surname>
<given-names><![CDATA[DR]]></given-names>
</name>
<name>
<surname><![CDATA[Feinstein]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Varon]]></surname>
<given-names><![CDATA[Aj]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of argininavasopresina during resuscitation from hemorrhagic hypotension after traumatic brain injury]]></article-title>
<source><![CDATA[Crit Care Med]]></source>
<year>2006</year>
<volume>34</volume>
<page-range>433-8</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lienhart]]></surname>
<given-names><![CDATA[HG]]></given-names>
</name>
<name>
<surname><![CDATA[Wenzel]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Braun]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Dörges]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Dünser]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gries]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vasopressin for therapy of persistent traumatic hemorrhagicshock: the VITRIS study]]></article-title>
<source><![CDATA[Anaesthesist]]></source>
<year>2007</year>
<volume>56</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>145-8</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lienhart]]></surname>
<given-names><![CDATA[HG]]></given-names>
</name>
<name>
<surname><![CDATA[Lindner]]></surname>
<given-names><![CDATA[KH]]></given-names>
</name>
<name>
<surname><![CDATA[Wenzel]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Developing alternative strategies for the treatment of traumatic]]></article-title>
<source><![CDATA[Curr Opin Crit Care]]></source>
<year>2008</year>
<volume>14</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>247-53</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chico-Fernández]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Llompart-Pou]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Guerrero-López]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Casado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[García-Sáez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Mayor-García]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of severe trauma in Spain. Registry of trauma in the ICU (RETRAUCI)]]></article-title>
<source><![CDATA[Med Intensiva]]></source>
<year>2016</year>
<volume>40</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>327-47</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Russell]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Walley]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Singer]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock (VASST)]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2008</year>
<volume>358</volume>
<page-range>877-87</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Luckner]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Arginine vasopressin in 316 patients with advanced vasodilatory shock]]></article-title>
<source><![CDATA[Crit Care Med]]></source>
<year>2005</year>
<volume>33</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2659-66</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Birkhahn]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Gaeta]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Terry]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bove]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Tloczkowski]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Shock index in diagnosing early acute hypovolemia]]></article-title>
<source><![CDATA[Am J Emerg Med]]></source>
<year>2005</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>323-6</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Acheampong]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vincent]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A positive fluid balance is an independent prognostic factor in patients with sepsis]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2015</year>
<volume>19</volume>
<page-range>251</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
